An observational study of acarbose treatment in patients with type 2 diabetes from the Middle East and Morocco

References

• International Diabetes Federation Atlas Available from: http://www.idf.org/diabetesatlas/5e/middle-east-and-north-africa Accessed November 22, 2012
   Google Scholar
• Wild S Roglic G Green A Sicree R King H Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 2004 27 1047 1053 15111519
   PubMed Web of Science ®Google Scholar
• Hossain P Kawar B El Nahas M Obesity and diabetes in the developing world: a growing challenge N Engl J Med 2007 356 213 215 17229948
   PubMed Web of Science ®Google Scholar
• Khutsoane D Sharama SK Almustafa M Biphasic insulin aspart 30 treatment improved glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study Diabetes Obes Metab 2008 10 212 222 18269636
   PubMed Web of Science ®Google Scholar
• Reed RL Revel AD Carter AO Saadi HF Dunn EV A controlled before-after trial of structured diabetes care in primary health centres in a newly developed country Int J Qual Health Care 2005 17 281 286 15831543
   PubMed Web of Science ®Google Scholar
• Belkhadir J el Ghomari H Klocker N Mikou A Nasciri M Sabri M Muslims with non-insulin dependent diabetes fasting during Ramadan: treatment with glibenclamide BMJ 1993 307 292 295 8374375
   PubMed Web of Science ®Google Scholar
• DECODE Study Group; the European Diabetes Epidemiology Group Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria Arch Intern Med 2001 161 397 405 11176766
   PubMed Web of Science ®Google Scholar
• Nakagami T DECODA Study Group Hyperglycaemia and mortality from all causes and from cardiovascular disease in 5 populations of Asian origin Diabetologia 2004 47 385 394 14985967
   PubMed Web of Science ®Google Scholar
• Hanefeld M Fischer S Julius U Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up Diabetologia 1996 39 1577 1583 8960845
   PubMed Web of Science ®Google Scholar
• Ceriello A Hanefeld M Leiter L Postprandial glucose regulation and diabetic complications Arch Intern Med 2004 164 2090 2095 15505121
   PubMed Web of Science ®Google Scholar
• Holman RR Cull CA Turner RC A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (UK Prospective Diabetes Study 44) Diabetes Care 1999 22 960 964 10372249
   PubMed Web of Science ®Google Scholar
• Lebovitz HE Alpha-glucosidase inhibitors as agents in the treatment of diabetes Diabetes Rev 1998 6 132 145
   Google Scholar
• Van de Laar FA Lucassen PL Akkermans RP van de Lisdonk EH Rutten GE van Weel C Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis Diabetes Care 2005 28 154 163 15616251
   PubMed Web of Science ®Google Scholar
• Hanefeld M Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes Cardiovasc Diabetol 2007 6 20 17697384
   PubMed Web of Science ®Google Scholar
• Hanefeld M Cagatay M Petrowitsch T Neuser D Petzinna D Rupp M Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies Eur Heart J 2004 25 10 16 14683737
   PubMed Web of Science ®Google Scholar
• Rosak C Haupt E Walter T Werner J The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia Diabetes Nutr Metab 2002 15 143 151 12173728
   PubMedGoogle Scholar
• Halimi S Le Berre MA Grangé V Efficacy and safety of acarbose add-on therapy in the treatment of overweight patients with type 2 diabetes inadequately controlled with metformin: a double-blind, placebo-controlled study Diabetes Res Clin Pract 2000 50 49 56 10936668
   PubMed Web of Science ®Google Scholar
• Li C Hung YJ Qamruddin K Aziz MF Stein H Schmidt B International noninterventional study of acarbose treatment in patients with type 2 diabetes mellitus Diabetes Res Clin Pract 2011 92 57 64 21251726
   PubMed Web of Science ®Google Scholar
• Fu AZ Qiu Y Radican L Yin DD Mavros P Preexisting cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: a matched cohort study Cardiovasc Diabetol 2010 9 15 20409333
   PubMed Web of Science ®Google Scholar
• American Diabetes Association Standards of medical care in diabetes – 2011 Diabetes Care 2011 34 Suppl 1 S11 S61 21193625
   PubMed Web of Science ®Google Scholar
• Hara T Nakamura J Kon N Sakakibara F Takeuchi N Hotta N An importance of carbohydrate ingestion for the expression of the effect of alpha-glucosidase inhibition Diabetes Care 1996 19 642 645 8725865
   PubMed Web of Science ®Google Scholar
• May C Wirksamkeit und Verträglichkeit von einschleichend dosierter Acarbose bei Patienten mit nichtinsulinpflichtigem Diabetes mellitus (Typ-II-Diabetes) unter Sulfonylharnstofftherapie Efficacy and tolerability of stepwise increasing dosage of acarbose in patients with non-insulin-dependent diabetes mellitus (NIDDM), treated with sulphonylureas Diabetes Stoffwechsel 1995 4 3 8 German
   Google Scholar
• Hollander P Safety profile of acarbose, an alpha-glucosidase inhibitor Drugs 1992 44 Suppl 3 47 53 1280577
   PubMedGoogle Scholar
• Mertes G Safety and efficacy of acarbose in the treatment of type 2 diabetes: data from a 5-year surveillance study Diabetes Res Clin Pract 2001 52 193 204 11323089
   PubMed Web of Science ®Google Scholar
• Buse J Hart K Minasi L The PROTECT study: final results of a large multicenter postmarketing study in patients with type 2 diabetes. Precose Resolution of Optimal Titration to Enhance Current Therapies Clin Ther 1998 20 257 269 9589817
   PubMed Web of Science ®Google Scholar
• Spengler M Schmitz H Landen H Evaluation of the efficacy and tolerability of acarbose in patients with diabetes mellitus: a postmarketing surveillance study Clin Drug Investig 2005 25 651 659
   PubMed Web of Science ®Google Scholar
• Spengler M Cagatay M The use of acarbose in the primary-care setting: evaluation of efficacy and tolerability of acarbose by postmarketing surveillance study Clin Invest Med 1995 18 325 331 8549020
   PubMed Web of Science ®Google Scholar
• Derosa G Maffioli P Efficacy and safety profile evaluation of acarbose alone and in association with other antidiabetic drugs: a systematic review Clin Ther 2012 34 1221 1236 22560622
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation Guideline for the management of postmeal glucose in diabetes 2011 Available from: http://www.idf.org/sites/default/files/postmeal%20glucose%20guidelines.pdf Accessed November 8, 2012
   Google Scholar
• International Diabetes Federation Treatment algorithm for people with type 2 diabetes Available from: http://www.idf.org/sites/default/files/Type%202%20treatment%20algorithm.pdf Accessed November 8, 2012
   Google Scholar